Trauma associated coagulopathy in the Intensive Care Unit
Abstract
Introduction: trauma is a global health problem. Trauma-associated coagulopathy constitutes a severe and multifactorial complication whose diagnosis is controversial.
Objectives: to assess the incidence of trauma-associated coagulopathy, the factors associated to the development of this condition and their impact on prognosis in a series of trauma patients admitted into the intensive care unit of our hospital.
Method: prospective study of all patients admitted to the ICU with a diagnosis of acute trauma. Trauma-associated coagulopathy was defined according to classical laboratory parameters, when it complies with one of the following: International normalized ratio (INR) greater than 1.3, thrombocytopenia smaller than 100000/mm3, and/or aPTT greater than 38 seconds. Continuous variables were expressed as the average ± standard deviation. The chi square analysis, Fisher exact test and binary logistic regression were performed, p < 0,05 being considered significant.
Results: 103 patients were analysed, average age was 33 years old and they were mostly male. Trauma-associated coagulopathy was found in 42 patients (40.8 %), and it was seen in most patients at the time they were hospitalized. Risk factors of trauma-associated coagulopathy were the following: severity upon hospitalization, shock, hypoperfusion, acidosis, massive transfusion, significant bleeding (univariate analysis); penetrating trauma and multi-organ dysfunction (multivariate analysis). No significant association between trauma- associated coagulopathy and mortality was found.
Conclusions: the study presents the first report on this topic in our country. Trauma associated coagulopathy is rather common in our population and it is seen upon hospitalization. This condition is related to severity and the kind of trauma. Early diagnosis is essential in the handling of patients with severe trauma.
References
2) Holcomb J. Major scientific lessons learned in the trauma field over the last two decades. PLoS Med 2017; 14(7): e1002339. doi: 10.1371/journal.pmed.1002339.
3) Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2095-128.
4) Centers for Disease Control and Prevention. Years of Potential Life Lost (YPLL) Reports, 1999–2015. WISQARS™, 2016. Disponible en: http://webappa.cdc.gov/sasweb/ ncipc/ypll10.html [Consulta: 12 abril 2020].
5) Holcomb J. What is new in the treatment of trauma induced coagulopathy? Expert Rev Hematol 2015; 8(6):703-5.
6) Spahn D, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt B, et al. European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care 2019; 23(1):98.
7) Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54(6):1127-30.
8) Maegele M. The diagnosis and treatment of acute traumatic bleeding and coagulopathy. Dtsch Arztebl Int 2019; 116(47):799-806.
9) Nassar A, Malbouisson L, Moreno R. Evaluation of simplified acute physiology score 3 performance: a systematic review of external validation studies. Crit Care 2014; 18(3):R117.
10) Baker S, O’Neill B, Haddon WJr, Long W. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14(3):187-96.
11) Vincent J, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter P, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26(11):1793-800.
12) Wafaisade A, Wutzler S, Lefering R, Tjardes T, Banerjee M, Paffrath T, et al. Drivers of acute coagulopathy after severe trauma: a multivariate analysis of 1987 patients. Emerg Med J 2010; 27(12):934-9.
13) Liu J, Tian H. Relationship between trauma-induced coagulopathy and progressive hemorrhagic injury in patients with traumatic brain injury. Chin J Traumatol 2016; 19(3):172-5.
14) MacLeod J, Winkler A, McCoy C, Hillyer C, Shaz B. Early trauma induced coagulopathy (ETIC): prevalence across the injury spectrum. Injury 2014; 45(5):910-5.
15) Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007; 38(3):298-304.
16) Cantle P, Cotton B. Prediction of massive transfusion in trauma. Crit Care Clin 2017; 33(1):71-84.
17) Mitra B, Cameron P, Gruen R, Mori A, Fitzgerald M, Street A, et al. The definition of massive transfusion in trauma: a critical variable in examining evidence for resuscitation. Eur J Emerg Med 2011; 18(3):137-42.
18) Savage S, Zarzaur B, Croce M, Fabian T. Redefining massive transfusion when every second counts. J Trauma Acute Care Surg 2013; 74(2):396-400.
19) Schoeneberg C, Schilling M, Hussmann B, Schmitz D, Lendemans S, Ruchholtz S. Preventable and potentially preventable deaths in severely injured patients: a retrospective analysis including patterns of errors. Eur J Trauma Emerg Surg 2017; 43(4):481-9.
20) Zhao W, Liu G, Tian Y, Song S, Li L. What’s new in trauma 2020. Chin J Traumatol 2021; 24(2):63-8. doi: 10.1016/ j.cjtee.2021.02.001.
21) Maegele M. The european perspective on the management of acute major hemorrhage and coagulopathy after trauma: summary of the 2019 Updated European Guideline. J Clin Med 2021; 10:362-74.
22) Chang R, Cardenas J, Wade C, Holcomb J. Advances in the understanding of trauma-induced coagulopathy. Blood 2016; 128(8):1043-9.
23) Kornblith L, Moore H, Cohen M. Trauma-induced coagulopathy: past, present and future. J Thromb Haemost 2019; 17(6):852-62.
24) Chang R, Kerby J, Kalkwarf K, Van Belle G, Fox E, Cotton A, et al. Earlier time to hemostasis is associated with decreased mortality and role of complications: results from the pragmatic randomized optimal platelet and plasma ratio trial. J Trauma Acute Care Surg 2019; 87(2):342-9.
25) Schäfer N, Driessen A, Fröhlich M, Stu¨rmer E, Maegele M. Diversity in clinical management and protocols for the treatment of major bleeding trauma patients across European level I Trauma Centres. Scand J Trauma Resusc Emerg Med 2015; 23:74. doi: 10.1186/s13049-015-0147-6.
26) Gangloff C, Mingant F, Theron M, Galinat H, Grimault O, Ozier Y, et al. New considerations on pathways involved in acute traumatic coagulopathy: the thrombin generation paradox. World J Emerg Surg 2019; 14:57. doi: 10.1186/ s13017-019-0276-8.
27) Dobson G, Morris J, Davenport L, Letson H. Traumatic-induced coagulopathy as a systems failure: a new window into hemostasis. Semin Thromb Hemost 2020; 46(2):199- 214.
28) Benes J, Zatloukal J, Kletecka J. Viscoelastic methods of blood clotting assessment - a multidisciplinary review. Front Med (Lausanne) 2015; 2:62. doi: 10.3389/fmed.2015.00062.
29) Gonzalez E, Moore E, Moore H, Chapman M, Silliman C, Banerjee A. Trauma-induced coagulopathy: an institution’s 35 year perspective on practice and research. Scand J Surg 2014; 103(02):89-103.
30) Rossaint R, Stanworth S, Curry N, Lefering R, Maegele M. Global characterisation of coagulopathy in isolated Traumatic Brain Injury (iTBI): a CENTER-TBI Analysis. Neurocrit Care 2020; 35(1):184-96. doi: 10.1007/ s12028- 020-01151-7.
31) Grille P, Calvo S. Disfunción de la coagulación en pacientes neurocríticos. En: Principios de hemoterapia en el paciente grave. Calvo S, Rodríguez Grecco eds. Editorial Cuadrado. Montevideo. 2014: Cap 8: 255-90. ISBN: 978-9974-31- 251-7.
32) Maegele M, Aversa J, Marsee M, McCauley R, Chitta S, Vyakaranam S, et al. Changes in coagulation following brain injury. Semin Thromb Hemost 2020; 46(2):155-66.
33) Maegele M, Schöchl H, Menovsky T, Maréchal H, Marklund N, Buki A, et al. Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management. Lancet Neurol 2017; 16(8):630-47.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
